SMC Global DistribusiAdvancing Care. Empowering Clinicians.
EN
Journals & Clinical Evidence

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

Curated research to understand technology benefits, comparisons, and limitations, prioritizing studies that identify devices or brands in our portfolio.

1 publication

General clinical evidence2016 · McEvoy RD et al.

CPAP, OSA symptoms, and cardiovascular outcomes

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
The New England journal of medicine

SAVE · Randomised trial · 2,717 adults with OSA and cardiovascular disease

Findings: CPAP improved snoring, daytime sleepiness, mood, and health-related quality of life.

Points to consider: Major cardiovascular events were not reduced in this population over an average 3.7 years; average use was 3.3 hours/night.

Device & relevance: CPAP evidence in OSA; the identity of the model offered must be assessed separately from the study findings.

DOI: 10.1056/nejmoa1606599